review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Tonya Bliss | Q91098177 |
Robert Andres | Q96114623 | ||
P2093 | author name string | Gary K Steinberg | |
P2860 | cites work | Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient | Q21090134 |
Mesenchymal stem cells avoid allogeneic rejection | Q21245658 | ||
Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. | Q24534130 | ||
Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model | Q24562969 | ||
Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect | Q24635138 | ||
Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome | Q28235047 | ||
Reprogramming of human somatic cells to pluripotency with defined factors | Q28262710 | ||
Translating the frontiers of brain repair to treatments: starting not to break the rules | Q28748979 | ||
Neuronal replacement from endogenous precursors in the adult brain after stroke | Q29615772 | ||
Mesenchymal progenitor cells in human umbilical cord blood | Q30168979 | ||
The ischemic penumbra: operationally defined by diffusion and perfusion MRI. | Q30583200 | ||
Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats | Q30724605 | ||
Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model | Q30841172 | ||
Grafted neural stem cells develop into functional pyramidal neurons and integrate into host cortical circuitry | Q30873232 | ||
Pooling of animal experimental data reveals influence of study design and publication bias | Q30918723 | ||
Ischemic cerebral tissue response to subventricular zone cell transplantation measured by iterative self-organizing data analysis technique algorithm | Q31033362 | ||
In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain | Q80718572 | ||
Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic | Q81230253 | ||
Autologous mesenchymal stem cell transplantation in stroke patients | Q81803888 | ||
Clinical trials of stroke therapy: which cells, which patients? | Q82876311 | ||
HuCNS-SC (StemCells) | Q83147761 | ||
Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia | Q44972813 | ||
Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume | Q45025359 | ||
Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke | Q45042816 | ||
Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells | Q45148313 | ||
Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model | Q45178238 | ||
PET imaging of herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk reporter gene expression in mice and humans using [18F]FHBG. | Q45405582 | ||
Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease | Q45861396 | ||
Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons | Q46123186 | ||
Positron emission tomography imaging of poststroke angiogenesis | Q46299767 | ||
Temporal profile of angiogenesis and expression of related genes in the brain after ischemia | Q46508396 | ||
The SPECT imaging shows the accumulation of neural progenitor cells into internal organs after systemic administration in middle cerebral artery occlusion rats | Q46524695 | ||
Reproductive hormones regulate the selective permeability of the blood-brain barrier | Q46670316 | ||
Bone marrow stromal cells increase astrocyte survival via upregulation of phosphoinositide 3-kinase/threonine protein kinase and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways and stimulate astrocyte trophic f | Q46730991 | ||
Allogeneic bone marrow stromal cells promote glial-axonal remodeling without immunologic sensitization after stroke in rats | Q46925001 | ||
Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats | Q47847785 | ||
Survival of fetal neocortical grafts implanted in brain infarcts of adult rats: the influence of postlesion time and age of donor tissue | Q48125442 | ||
One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke | Q48156405 | ||
Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage | Q48244314 | ||
In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance | Q48261648 | ||
Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke | Q48262046 | ||
Enriched environment enhances transplanted subventricular zone stem cell migration and functional recovery after stroke | Q48263232 | ||
No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage | Q48290505 | ||
Tracking neural stem cells in patients with brain trauma | Q48352456 | ||
MRI monitoring of neuroinflammation in mouse focal ischemia. | Q48361026 | ||
Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats | Q48385344 | ||
Magnetic resonance imaging and neurosphere therapy of stroke in rat. | Q48399167 | ||
Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats | Q48675224 | ||
Stem cells with brainpower. | Q48697164 | ||
Extensive cortical rewiring after brain injury. | Q48708297 | ||
Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats | Q48721941 | ||
Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage | Q48734158 | ||
Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery | Q48784825 | ||
Angiogenesis and functional recovery demonstrated after minor stroke | Q48787363 | ||
Glial responses, neuron death and lesion resolution after intracerebral hemorrhage in young vs. aged rats. | Q48857393 | ||
Long-term assessment of enriched housing and subventricular zone derived cell transplantation after focal ischemia in rats | Q49016797 | ||
Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat. | Q49087443 | ||
Magnetically labeled cells can be detected by MR imaging | Q49116536 | ||
Mapping the ischaemic penumbra with PET: a new approach | Q49125855 | ||
Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. | Q51575936 | ||
Live imaging of neuroinflammation reveals sex and estrogen effects on astrocyte response to ischemic injury. | Q51716002 | ||
Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression | Q61709571 | ||
Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats | Q71544204 | ||
Influence of an Enriched Environment and Cortical Grafting on Functional Outcome in Brain Infarcts of Adult Rats | Q71846033 | ||
Prognostic value of blood vessel density in ischaemic stroke | Q72231811 | ||
Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases | Q73180485 | ||
Keeping in touch with angiogenesis | Q73606546 | ||
Stem cells: the good, bad and barely in control | Q79334829 | ||
Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke | Q80399919 | ||
Human neural stem/progenitor cells, expanded in long-term neurosphere culture, promote functional recovery after focal ischemia in Mongolian gerbils | Q80587783 | ||
Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G | Q80714885 | ||
Imaging inflammation in acute brain ischemia | Q31096456 | ||
Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. | Q33237964 | ||
Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration | Q33387798 | ||
Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. | Q33713837 | ||
Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta | Q33855709 | ||
Intravenous mesenchymal stem cell therapy for traumatic brain injury | Q33929697 | ||
Imaging transgene expression with radionuclide imaging technologies | Q33995799 | ||
The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue | Q34154476 | ||
Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro | Q34266569 | ||
Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. | Q34416007 | ||
Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. | Q34433743 | ||
Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke | Q34468850 | ||
Anti-inflammatory effects of human cord blood cells in a rat model of stroke | Q34469782 | ||
Do bone marrow stromal cells proliferate after transplantation into mice cerebral infarct?--a double labeling study | Q34470913 | ||
Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke | Q34510705 | ||
Themes and strategies for studying the biology of stroke recovery in the poststroke epoch | Q34756746 | ||
A new penumbra: transitioning from injury into repair after stroke | Q34777115 | ||
Astrocytes and brain injury | Q35061615 | ||
Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat | Q35298897 | ||
Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation | Q35789004 | ||
Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. | Q35840475 | ||
Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells | Q36051656 | ||
Astrocytes in cerebral ischemic injury: morphological and general considerations | Q36104657 | ||
Signaling between glia and neurons: focus on synaptic plasticity | Q36250169 | ||
Use of human umbilical cord blood (HUCB) cells to repair the damaged brain | Q36266128 | ||
Mechanisms of brain injury after intracerebral haemorrhage. | Q36345249 | ||
Bench to bedside: the quest for quality in experimental stroke research | Q36416843 | ||
Cellular and molecular mechanisms of neural repair after stroke: making waves. | Q36457986 | ||
Brain injury after intracerebral hemorrhage: the role of thrombin and iron. | Q36721668 | ||
Cell transplantation therapy for stroke | Q36721703 | ||
Pathways to ischemic neuronal cell death: are sex differences relevant? | Q36761504 | ||
Cell-cell signaling in the neurovascular unit | Q36801092 | ||
Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury | Q36866091 | ||
Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses | Q36936307 | ||
Development of a human neural stem cell line for use in recovery from disability after stroke | Q36992430 | ||
Stroke and the female brain | Q37058753 | ||
Intravascular cell replacement therapy for stroke | Q37110216 | ||
Cell replacement therapy for intracerebral hemorrhage | Q37110219 | ||
A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration | Q37117718 | ||
Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes | Q37149840 | ||
Potential of adult neural stem cells in stroke therapy | Q37306810 | ||
Stem cell therapy in stroke. | Q37319445 | ||
Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke | Q37354712 | ||
Changes in experimental stroke outcome across the life span | Q37356917 | ||
Inflammation and stem cell migration to the injured brain in higher organisms | Q37387232 | ||
Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. | Q37416265 | ||
Challenges and possibilities of intravascular cell therapy in stroke. | Q37424810 | ||
Suppression of inflammation in ischemic and hemorrhagic stroke: therapeutic options | Q37478454 | ||
Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors | Q39185849 | ||
The support of neural stem cells transplanted into stroke-induced brain cavities by PLGA particles | Q39874302 | ||
Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model | Q40007652 | ||
Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects | Q40149368 | ||
Imaging of mesenchymal stem cell transplant by bioluminescence and PET. | Q40153838 | ||
Transplantation of hNT neurons into the ischemic cortex: cell survival and effect on sensorimotor behavior. | Q40312503 | ||
A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke | Q40319588 | ||
Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury | Q40325769 | ||
Primate embryonic stem cell-derived neuronal progenitors transplanted into ischemic brain | Q40333561 | ||
Delayed transplantation of human neurons following brain injury in rats: a long-term graft survival and behavior study | Q40335880 | ||
Transplantation of neural cells derived from retinoic acid-treated cynomolgus monkey embryonic stem cells successfully improved motor function of hemiplegic mice with experimental brain injury | Q40378928 | ||
Immortalized neural stem cells differ from nonimmortalized cortical neurospheres and cerebellar granule cell progenitors. | Q40397321 | ||
Implantable Biohybrid Artificial Organs | Q40427311 | ||
Imaging of stem cell recruitment to ischemic infarcts in a murine model | Q40584879 | ||
Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study | Q40596117 | ||
Neural progenitors from human embryonic stem cells. | Q40673316 | ||
Effects of implantation site of stem cell grafts on behavioral recovery from stroke damage | Q40705912 | ||
Neural transplantation of human neuroteratocarcinoma (hNT) neurons into ischemic rats. A quantitative dose-response analysis of cell survival and behavioral recovery | Q40948648 | ||
Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats | Q41059720 | ||
Endothelial cell precursors are normal components of human umbilical cord blood | Q41087418 | ||
Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study | Q42480335 | ||
Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial | Q42483132 | ||
Transplantation of cultured human neuronal cells for patients with stroke | Q42492334 | ||
Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke | Q42949636 | ||
Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas | Q43733716 | ||
Grafting neural stem cells improved the impaired spatial recognition in ischemic rats | Q43807480 | ||
In vitro differentiation of transplantable neural precursors from human embryonic stem cells | Q43814659 | ||
Hemoglobin-induced cytotoxicity in rat cerebral cortical neurons: caspase activation and oxidative stress | Q44053944 | ||
Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery | Q44115092 | ||
Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation | Q44317237 | ||
Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. | Q44569653 | ||
A safer stem cell: on guard against cancer | Q44904671 | ||
P433 | issue | 2 | |
P304 | page(s) | 275-283 | |
P577 | publication date | 2009-10-12 | |
P1433 | published in | Neurobiology of Disease | Q15716606 |
P1476 | title | Optimizing the success of cell transplantation therapy for stroke | |
P478 | volume | 37 |
Q90259671 | A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair after Ischemic Injury through In Vivo Astrocyte-to-Neuron Conversion |
Q35746310 | Advances in regenerative therapies for spinal cord injury: a biomaterials approach |
Q46265702 | Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients. |
Q26740083 | Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies |
Q38210965 | Bone marrow stromal cells as a therapeutic treatment for ischemic stroke |
Q28254272 | CXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice |
Q27025754 | Cell based therapies for ischemic stroke: from basic science to bedside |
Q34269972 | Cell therapy for neonatal hypoxia-ischemia and cerebral palsy |
Q38010728 | Cellular replacement and regenerative medicine therapies in ischemic stroke |
Q52603055 | Cerebral ischemia and neuroregeneration. |
Q39554131 | Challenges enrolling patients with acute ischemic stroke into cell therapy trials |
Q42043958 | Comparison of the therapeutic effects of bone marrow mononuclear cells and microglia for permanent cerebral ischemia |
Q48100040 | Concise Review: Extracellular Vesicles Overcoming Limitations of Cell Therapies in Ischemic Stroke. |
Q57214366 | Cortical Reshaping and Functional Recovery Induced by Silk Fibroin Hydrogels-Encapsulated Stem Cells Implanted in Stroke Animals |
Q34306382 | Delayed transplantation of human neural precursor cells improves outcome from focal cerebral ischemia in aged rats |
Q35881817 | Delivery of iPS-NPCs to the Stroke Cavity within a Hyaluronic Acid Matrix Promotes the Differentiation of Transplanted Cells. |
Q38105080 | Devices for cell transplantation into the central nervous system: Design considerations and emerging technologies |
Q35679579 | Effects of acute versus post-acute systemic delivery of neural progenitor cells on neurological recovery and brain remodeling after focal cerebral ischemia in mice |
Q30594942 | Effects of neural progenitor cells on post-stroke neurological impairment-a detailed and comprehensive analysis of behavioral tests |
Q34599756 | Efficacy and safety of stem cell therapies for patients with stroke: a systematic review and single arm meta-analysis |
Q37882518 | Experimental approaches to study functional recovery following cerebral ischemia. |
Q36067866 | Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression |
Q33710389 | From Atom to Brain: Applications of Molecular Imaging to Neurosurgery |
Q26823623 | Glycosaminoglycans and glycomimetics in the central nervous system |
Q36685619 | History of Neural Stem Cell Research and Its Clinical Application |
Q30571926 | Homing of neural stem cells from the venous compartment into a brain infarct does not involve conventional interactions with vascular endothelium |
Q47247910 | Human Muse Cells Reconstruct Neuronal Circuitry in Subacute Lacunar Stroke Model |
Q39298289 | Human induced pluripotent stem cells improve stroke outcome and reduce secondary degeneration in the recipient brain |
Q35007872 | Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain |
Q38090924 | Hyaluronan, neural stem cells and tissue reconstruction after acute ischemic stroke. |
Q36419960 | Hydrogel matrix to support stem cell survival after brain transplantation in stroke. |
Q38651258 | Hydrogels for central nervous system therapeutic strategies |
Q92977570 | Hydrogels-Assisted Cell Engraftment for Repairing the Stroke-Damaged Brain: Chimera or Reality |
Q51287822 | IGF1R+ Dental Pulp Stem Cells Enhanced Neuroplasticity in Hypoxia-Ischemia Model. |
Q34392864 | Impact of age on the efficacy of bone marrow mononuclear cell transplantation in experimental stroke |
Q39258990 | In vivo and in vitro characterization of the angiogenic effect of CTX0E03 human neural stem cells |
Q37812276 | In vivo imaging of embryonic stem cell therapy |
Q38885623 | Injected Versus Oral Cyclosporine for Human Neural Progenitor Grafting in Rats |
Q36411048 | Interleukin 6-preconditioned neural stem cells reduce ischaemic injury in stroke mice. |
Q52719694 | Interleukin-1 receptor antagonist-mediated neuroprotection by umbilical cord-derived mesenchymal stromal cells following transplantation into a rodent stroke model. |
Q36645434 | Intracerebroventricular Transplantation of Cord Blood-Derived Neural Progenitors in a Child With Severe Global Brain Ischemic Injury |
Q38170033 | Intravascular stem cell transplantation for stroke |
Q49015926 | Intravenous autologous bone marrow mononuclear cells for ischemic stroke |
Q35632221 | Intravenously delivered neural stem cells migrate into ischemic brain, differentiate and improve functional recovery after transient ischemic stroke in adult rats |
Q48934380 | Ischemia, immunosuppression, and SSEA-1-negative cells all contribute to tumors resulting from mouse embryonic stem cell-derived neural progenitor transplantation |
Q26828783 | Magnetic resonance imaging of transplanted stem cell fate in stroke |
Q26799905 | Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury |
Q39249577 | Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats. |
Q35243356 | Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model. |
Q44814731 | Micro/nano-engineering to control growth of neuronal cells and tissue engineering applied to the central nervous system |
Q49093501 | Multiple cell transplantation based on an intraparenchymal approach for patients with chronic phase stroke |
Q36014178 | Neural stem cell transplantation promotes behavioral recovery in a photothrombosis stroke model. |
Q41884863 | Neural stem cells genetically modified to overexpress cu/zn-superoxide dismutase enhance amelioration of ischemic stroke in mice. |
Q48983019 | Neural stem/progenitor cell transplantation for cortical visual impairment in neonatal brain injured patients |
Q38778700 | Neurogenesis in Stroke Recovery |
Q37028288 | Neurorestoration after stroke. |
Q26800178 | Novel Stroke Therapeutics: Unraveling Stroke Pathophysiology and Its Impact on Clinical Treatments |
Q58785850 | On the Viability and Potential Value of Stem Cells for Repair and Treatment of Central Neurotrauma: Overview and Speculations |
Q27000069 | Pathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal models |
Q37282339 | Perspectives for computational modeling of cell replacement for neurological disorders |
Q88405456 | Pharmacological approaches promoting stem cell-based therapy following ischemic stroke insults |
Q33862295 | Preclinical Studies and Translational Applications of Intracerebral Hemorrhage. |
Q42267329 | Priming of the Cells: Hypoxic Preconditioning for Stem Cell Therapy |
Q34806181 | Prognostic value of changes in resting-state functional connectivity patterns in cognitive recovery after stroke: A 3T fMRI pilot study. |
Q37794781 | Progress and prospects: stem cells and neurological diseases |
Q37086202 | Radially branched deployment for more efficient cell transplantation at the scale of the human brain. |
Q53159214 | Recent advances in basic and translational stroke research. |
Q37864499 | Regenerative medicine for stroke - are we there yet? |
Q38133954 | Regenerative therapies for central nervous system diseases: a biomaterials approach |
Q99617428 | Safety and Efficacy of Stem Cell Therapy in Patients With Ischemic Stroke |
Q36514722 | Scaffolds for Intracerebral Grafting of Neural Progenitor Cells After Cerebral Infarction: A Systematic Review |
Q91781221 | Silencing of SNHG12 Enhanced the Effectiveness of MSCs in Alleviating Ischemia/Reperfusion Injuries via the PI3K/AKT/mTOR Signaling Pathway |
Q88561849 | Stem Cell-Based Immunomodulation After Stroke: Effects on Brain Repair Processes |
Q39017141 | Stem cell therapies in age-related neurodegenerative diseases and stroke |
Q26866149 | Stem cell therapy for acute cerebral injury: what do we know and what will the future bring? |
Q35501361 | Stem cell therapy in intracerebral hemorrhage rat model |
Q36917699 | Stem cell therapy in stroke: a review literature |
Q38369063 | Stem cell transplantation enhances endogenous brain repair after experimental stroke |
Q34419548 | Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability |
Q35006313 | Stem cell-like dog placenta cells afford neuroprotection against ischemic stroke model via heat shock protein upregulation |
Q34923168 | Stem cells and stroke: opportunities, challenges and strategies |
Q38019968 | Stem cells in stroke treatment: the promise and the challenges. |
Q37298275 | TAT-Hsp70 induces neuroprotection against stroke via anti-inflammatory actions providing appropriate cellular microenvironment for transplantation of neural precursor cells |
Q52721246 | TNF-α induces human neural progenitor cell survival after oxygen-glucose deprivation by activating the NF-κB pathway. |
Q89701447 | The effect of Matrigel as scaffold material for neural stem cell transplantation for treating spinal cord injury |
Q42396489 | The effect of injection using narrow-bore needles on mammalian cells: administration and formulation considerations for cell therapies |
Q36898956 | The emerging role of epigenetics in stroke: III. Neural stem cell biology and regenerative medicine |
Q36318376 | The potential benefit of stem cell therapy after stroke: an update |
Q37025630 | The rise of cell therapy trials for stroke: review of published and registered studies |
Q38099747 | Therapeutic applications of bone marrow-derived stem cells in ischemic stroke |
Q87041085 | Timing and dose regimens of marrow mesenchymal stem cell transplantation affect the outcomes and neuroinflammatory response after ischemic stroke |
Q39347126 | Transduction of neural precursor cells with TAT-heat shock protein 70 chaperone: therapeutic potential against ischemic stroke after intrastriatal and systemic transplantation |
Q28748979 | Translating the frontiers of brain repair to treatments: starting not to break the rules |
Q53476373 | Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges. |
Q34494917 | Transplantation of Unique Subpopulation of Fibroblasts, Muse Cells, Ameliorates Experimental Stroke Possibly via Robust Neuronal Differentiation |
Q30563960 | Transplantation of cryopreserved human umbilical cord blood mononuclear cells does not induce sustained recovery after experimental stroke in spontaneously hypertensive rats |
Q93379108 | Treatment of multiple system atrophy - the past, present and future |
Q37997539 | Trophic factors and cell therapy to stimulate brain repair after ischaemic stroke. |
Q38139296 | Update on therapeutic mechanism for bone marrow stromal cells in ischemic stroke |
Search more.